Co-Authors
This is a "connection" page, showing publications co-authored by DAN S GOMBOS and PATRICK HWU.
Connection Strength
0.305
-
GPNMB expression in uveal melanoma: a potential for targeted therapy. Melanoma Res. 2010 Jun; 20(3):184-90.
Score: 0.091
-
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. J Immunother Cancer. 2020 11; 8(2).
Score: 0.047
-
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study. J Clin Oncol. 2021 02 20; 39(6):599-607.
Score: 0.047
-
Adjuvant Ipilimumab in High-Risk Uveal Melanoma. Cancers (Basel). 2019 Jan 29; 11(2).
Score: 0.042
-
Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma. J Immunother. 2018 Nov/Dec; 41(9):399-405.
Score: 0.041
-
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study. Oncoimmunology. 2017; 6(6):e1321187.
Score: 0.037